Page 1 of Clinical Trials for Peplin [SPONSOR-COLLABORATORS], 29 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
Last Updated: March 21, 2012
Condition(s): Actinic Keratoses
2
Completed
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
Last Updated: April 30, 2012
Condition(s): Actinic Keratosis
3
Completed
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Last Updated: March 29, 2012
Condition(s): Actinic Keratosis
4
Withdrawn
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
Last Updated: February 13, 2008
Condition(s): Warts
5
Completed
A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers
Last Updated: April 16, 2009
Condition(s): Actinic Keratosis
6
Completed
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
Last Updated: October 19, 2010
Condition(s): Actinic Keratosis
7
Completed
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
Last Updated: December 22, 2008
Condition(s): Healthy
8
Completed
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma
Last Updated: December 22, 2008
Condition(s): Basal Cell Carcinoma
9
Completed
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Last Updated: December 22, 2008
Condition(s): Carcinoma, Squamous Cell
10
Completed
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
Last Updated: May 3, 2012
Condition(s): Healthy; Actinic Keratosis
11
Completed
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Last Updated: October 6, 2010
Condition(s): Actinic Keratosis
12
Completed
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma
Last Updated: December 22, 2008
Condition(s): Basal Cell Carcinoma
13
Completed
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Last Updated: December 22, 2008
Condition(s): Keratosis
14
Completed
A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis
Last Updated: July 18, 2010
Condition(s): Actinic Keratosis
15
Completed
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
Last Updated: December 22, 2008
Condition(s): Actinic Keratosis
16
Completed
A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Last Updated: December 22, 2008
Condition(s): Actinic Keratoses
17
Completed
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Last Updated: March 21, 2012
Condition(s): Actinic Keratosis
18
Completed
Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005
Last Updated: May 22, 2008
Condition(s): Actinic Keratoses
19
Completed
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
Last Updated: July 15, 2010
Condition(s): Actinic Keratosis
20
Completed
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
Last Updated: January 23, 2011
Condition(s): Seborrheic Keratosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Peplin

Page 1 of Clinical Trials for Peplin [SPONSOR-COLLABORATORS], 29 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About